Guoping Cheng
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 3
- Cancer Cells and Metastasis 3
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Zhengbo Song (6 shared papers)Kaiyan Chen (6 shared papers)Fanrong Zhang (5 shared papers)Yiping Zhang (3 shared papers)Yun Fan (5 shared papers)Yanjun Xu (3 shared papers)Xinmin Yu (1 shared paper)Zhijian Cai (2 shared papers)
- Journals
- OncoTargets and Therapy (4 papers)Cell Death and Disease (3 papers)Oncotarget (3 papers)Lung Cancer (2 papers)Annals of Surgical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Guoping Cheng
40 papers receiving 920 citations
Peers
Comparison fields: 5 of 90
- Oncology 406
- Cancer Research 155
- Pulmonary and Respiratory Medicine 282
- Immunology 124
- Health Informatics 5
Countries citing papers authored by Guoping Cheng
This map shows the geographic impact of Guoping Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoping Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoping Cheng more than expected).
Fields of papers citing papers by Guoping Cheng
This network shows the impact of papers produced by Guoping Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoping Cheng. The network helps show where Guoping Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoping Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 151 | |
| 2 | 2016 | 95 | |
| 3 | 2020 | 73 | |
| 4 | 2016 | 67 | |
| 5 | 2020 | 49 | |
| 6 | 2022 | 48 | |
| 7 | 2018 | 39 | |
| 8 | 2019 | 32 | |
| 9 | 2017 | 30 | |
| 10 | 2017 | 26 | |
| 11 | 2020 | 24 | |
| 12 | 2022 | 23 | |
| 13 | 2021 | 21 | |
| 14 | 2019 | 21 | |
| 15 | 2018 | 19 | |
| 16 | 2021 | 19 | |
| 17 | 2020 | 18 | |
| 18 | 2022 | 17 | |
| 19 | 2015 | 16 | |
| 20 | 2017 | 15 |
About Guoping Cheng
Guoping Cheng is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Immunology and Immunology and Allergy, having authored 40 papers that have together received 926 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer Cells and Metastasis (3 papers), Cancer-related molecular mechanisms research (2 papers), Cell Adhesion Molecules Research (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Oncology (406 citations), Cancer Research (155 citations), Pulmonary and Respiratory Medicine (282 citations), Immunology (124 citations) and Health Informatics (5 citations). Guoping Cheng has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhengbo Song, Kaiyan Chen, Fanrong Zhang, Yiping Zhang, Yun Fan, Yanjun Xu, Xinmin Yu, Zhijian Cai, Yanmei Peng and Xiaofang Huang. Their work appears in journals such as OncoTargets and Therapy, Cell Death and Disease, Oncotarget, Lung Cancer and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.